finasteride Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
testosterone reductase inhibitors 1171 98319-26-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • finasteride
  • finastid
  • prosteride
  • prostide
  • propecia
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
  • Molecular weight: 372.55
  • Formula: C23H36N2O2
  • CLOGP: 3.01
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 2
  • TPSA: 58.20
  • ALOGS: -5.27
  • ROTB: 2

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
1 mg O
5 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.04 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.19 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 63 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 1.10 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 2.40 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.10 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 6 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
June 19, 1992 FDA MERCK

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Exposure via body fluid 267.57 244.92 31 110 247 2357697

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Erectile dysfunction 5678.59 52.37 960 1731 3537 1740553
Sexual dysfunction 5566.83 52.37 837 1854 986 1743104
Depression 2876.27 52.37 684 2007 15985 1728105
Libido decreased 2701.27 52.37 434 2257 891 1743199
Anxiety 2560.42 52.37 616 2075 14911 1729179
Cognitive disorder 2441.56 52.37 475 2216 3855 1740235
Loss of libido 2161.67 52.37 331 2360 397 1743693
Ejaculation disorder 1442.40 52.37 222 2469 272 1743818
Semen volume decreased 1356.50 52.37 193 2498 58 1744032
Gynaecomastia 1033.57 52.37 208 2483 1924 1742166
Hypogonadism 960.50 52.37 149 2542 195 1743895
Ejaculation failure 956.91 52.37 151 2540 238 1743852
Testicular pain 898.94 52.37 156 2535 559 1743531
Blood testosterone decreased 890.24 52.37 164 2527 888 1743202
Penile size reduced 703.21 52.37 103 2588 58 1744032
Organic erectile dysfunction 639.35 52.37 92 2599 35 1744055
Hormone level abnormal 633.66 52.37 96 2595 92 1743998
Insomnia 570.79 52.37 197 2494 16079 1728011
Fatigue 564.39 52.37 268 2423 50513 1693577
Product administration error 561.76 52.37 134 2557 2819 1741271
Penis injury 492.42 52.37 71 2620 28 1744062
Testicular atrophy 485.25 52.37 76 2615 108 1743982
Suicidal ideation 467.32 52.37 145 2546 8373 1735717
Peyronie's disease 434.23 52.37 70 2621 133 1743957
Brain injury 429.35 52.37 89 2602 942 1743148
Testicular disorder 392.81 52.37 64 2627 134 1743956
Benign prostatic hyperplasia 380.30 52.37 85 2606 1313 1742777
Hyperlipidaemia 376.29 52.37 92 2599 2137 1741953
Prostatitis 370.05 52.37 78 2613 899 1743191
Varicocele 363.20 52.37 53 2638 27 1744063
Disturbance in attention 353.79 52.37 100 2591 4134 1739956
Panic attack 351.32 52.37 84 2607 1768 1742322
Wrong technique in product usage process 350.36 52.37 123 2568 10412 1733678
Hypertension 350.31 52.37 145 2546 19303 1724787
Penis disorder 345.47 52.37 63 2628 312 1743778
Painful ejaculation 340.59 52.37 49 2642 18 1744072
Genital hypoaesthesia 340.39 52.37 51 2640 41 1744049
Emotional distress 319.31 52.37 78 2613 1800 1742290
Gastrooesophageal reflux disease 318.06 52.37 94 2597 4553 1739537
Endocrine disorder 289.15 52.37 45 2646 59 1744031
Back pain 285.70 52.37 120 2571 16493 1727597
Stress 283.41 52.37 76 2615 2565 1741525
Testicular failure 277.74 52.37 40 2651 15 1744075
Hypogonadism male 276.44 52.37 43 2648 56 1744034
Nocturia 274.48 52.37 63 2628 1098 1742992
Dysuria 258.62 52.37 76 2615 3596 1740494
Alopecia 243.90 52.37 73 2618 3680 1740410
Male orgasmic disorder 239.24 52.37 37 2654 45 1744045
Orgasm abnormal 238.35 52.37 37 2654 47 1744043
Muscle atrophy 235.74 52.37 56 2635 1139 1742951
Feeling abnormal 233.79 52.37 93 2598 11073 1733017
Epididymal cyst 226.56 52.37 33 2658 16 1744074
Sleep apnoea syndrome 226.33 52.37 61 2630 2093 1741997
Major depression 224.88 52.37 49 2642 664 1743426
Amnesia 224.85 52.37 73 2618 4818 1739272
Asthenia 223.23 52.37 128 2563 34542 1709548
Headache 221.55 52.37 127 2564 34249 1709841
Drug ineffective 216.12 52.37 157 2534 63644 1680446
Androgen deficiency 208.78 52.37 33 2658 51 1744039
Pollakiuria 207.44 52.37 61 2630 2885 1741205
Anorgasmia 205.91 52.37 37 2654 165 1743925
Arthralgia 201.75 52.37 105 2586 23339 1720751
Hair transplant 200.42 52.37 28 2663 3 1744087
Attention deficit/hyperactivity disorder 197.16 52.37 41 2650 437 1743653
Semen analysis abnormal 196.54 52.37 29 2662 18 1744072
Sleep disorder 192.20 52.37 62 2629 4001 1740089
Infertility male 187.33 52.37 33 2658 128 1743962
Adverse event 183.74 52.37 62 2629 4606 1739484
Sperm concentration decreased 182.62 52.37 31 2660 91 1743999
Urine flow decreased 180.68 52.37 35 2656 251 1743839
Hypercholesterolaemia 178.93 52.37 45 2646 1167 1742923
Melanocytic naevus 177.93 52.37 37 2654 394 1743696
Male reproductive tract disorder 173.57 52.37 27 2664 35 1744055
Memory impairment 173.06 52.37 65 2626 6598 1737492
Infertility 166.33 52.37 30 2661 137 1743953
Penile pain 164.91 52.37 33 2658 285 1743805
Premature ejaculation 163.82 52.37 27 2664 62 1744028
Dizziness 159.37 52.37 103 2588 34258 1709832
Prostate cancer 156.96 52.37 55 2636 4571 1739519
Weight increased 155.36 52.37 70 2621 11287 1732803
Blood cholesterol increased 154.64 52.37 49 2642 2977 1741113
Palpitations 153.72 52.37 60 2631 6754 1737336
Tonsillectomy 153.19 52.37 27 2664 105 1743985
Epididymitis 152.09 52.37 32 2659 362 1743728
Haemorrhoids 151.67 52.37 43 2648 1778 1742312
Vitamin D deficiency 149.89 52.37 33 2658 469 1743621
Tinnitus 139.83 52.37 46 2645 3149 1740941
Generalised anxiety disorder 139.72 52.37 25 2666 108 1743982
Knee operation 138.52 52.37 30 2661 393 1743697
Acne 138.49 52.37 40 2651 1768 1742322
Orgasmic sensation decreased 138.38 52.37 21 2670 20 1744070
Reproductive tract disorder 137.73 52.37 20 2671 9 1744081
Breast enlargement 135.42 52.37 25 2666 133 1743957
Apathy 132.72 52.37 36 2655 1260 1742830
Hydrocele 131.69 52.37 28 2663 334 1743756
Rhinitis allergic 130.56 52.37 28 2663 349 1743741
Urinary retention 130.50 52.37 50 2641 5345 1738745
Male genital atrophy 127.87 52.37 18 2673 3 1744087
Hypoaesthesia 126.15 52.37 58 2633 9777 1734313
Vasectomy 123.29 52.37 19 2672 22 1744068
Azoospermia 122.67 52.37 24 2667 182 1743908
Road traffic accident 122.66 52.37 43 2648 3570 1740520
Haematuria 120.73 52.37 52 2639 7508 1736582
Osteoarthritis 120.67 52.37 38 2653 2258 1741832
Prostatomegaly 119.51 52.37 29 2662 644 1743446
Muscle strain 118.31 52.37 28 2663 557 1743533
Chest pain 118.22 52.37 70 2621 19844 1724246
Male sexual dysfunction 117.21 52.37 20 2671 61 1744029
Hypothyroidism 116.60 52.37 38 2653 2522 1741568
Back injury 115.98 52.37 28 2663 608 1743482
Groin pain 115.37 52.37 29 2662 748 1743342
Vision blurred 115.33 52.37 52 2639 8371 1735719
Joint injury 114.95 52.37 31 2660 1060 1743030
Breast tenderness 114.15 52.37 23 2668 206 1743884
Dry skin 113.95 52.37 41 2650 3671 1740419
Pain 113.79 52.37 76 2615 26581 1717509
Intervertebral disc protrusion 113.74 52.37 33 2658 1480 1742610
Disturbance in sexual arousal 113.40 52.37 20 2671 78 1744012
Eczema 111.96 52.37 36 2655 2288 1741802
Breast mass 111.06 52.37 22 2669 179 1743911
Upper respiratory tract infection 110.04 52.37 41 2650 4052 1740038
Myalgia 108.77 52.37 61 2630 15597 1728493
Ligament sprain 108.51 52.37 25 2666 440 1743650
Nephrolithiasis 107.36 52.37 40 2651 3952 1740138
Essential hypertension 107.05 52.37 23 2668 289 1743801
Lower urinary tract symptoms 107.00 52.37 18 2673 49 1744041
Neck pain 106.41 52.37 38 2653 3328 1740762
Obesity 105.93 52.37 29 2662 1050 1743040
Irritable bowel syndrome 103.76 52.37 25 2666 538 1743552
Hernia repair 102.87 52.37 22 2669 270 1743820
Asthma 95.92 52.37 39 2652 4865 1739225
Spermatocele 94.06 52.37 14 2677 10 1744080
Skin disorder 94.00 52.37 31 2660 2133 1741957
Anogenital warts 93.62 52.37 18 2673 123 1743967
Dyspepsia 91.90 52.37 38 2653 4947 1739143
Emotional disorder 91.37 52.37 26 2665 1086 1743004
Stress at work 91.20 52.37 16 2675 60 1744030
Seborrhoeic dermatitis 91.16 52.37 19 2672 204 1743886
Wisdom teeth removal 89.80 52.37 16 2675 67 1744023
Perineal pain 89.80 52.37 16 2675 67 1744023
Dermal cyst 89.69 52.37 19 2672 222 1743868
Prostatic specific antigen increased 89.06 52.37 31 2660 2515 1741575
Prostatic pain 88.58 52.37 15 2676 43 1744047
Muscle spasms 88.11 52.37 48 2643 11573 1732517
Secondary hypogonadism 87.98 52.37 16 2675 77 1744013
Dihydrotestosterone decreased 87.08 52.37 12 2679 0 1744090
Adverse drug reaction 86.94 52.37 36 2655 4702 1739388
Soft tissue injury 86.88 52.37 15 2676 50 1744040
Oligospermia 86.23 52.37 14 2677 28 1744062
Penile curvature 85.90 52.37 14 2677 29 1744061
Lipoma 85.74 52.37 19 2672 278 1743812
Completed suicide 85.51 52.37 53 2638 16259 1727831
Granulomatous rosacea 85.23 52.37 12 2679 2 1744088
Sensory loss 84.88 52.37 23 2668 800 1743290
Dyslipidaemia 84.82 52.37 23 2668 802 1743288
Rash 84.45 52.37 74 2617 38619 1705471
Paraesthesia 84.34 52.37 45 2646 10406 1733684
Self esteem decreased 84.18 52.37 17 2674 154 1743936
Renal cyst 84.02 52.37 24 2667 1016 1743074
Nasal septum deviation 83.59 52.37 17 2674 160 1743930
Social anxiety disorder 83.21 52.37 15 2676 68 1744022
Haematospermia 81.91 52.37 16 2675 120 1743970
Panic disorder 81.37 52.37 18 2673 261 1743829
Marital problem 81.01 52.37 14 2677 47 1744043
Skin papilloma 80.68 52.37 19 2672 369 1743721
Sinusitis 80.28 52.37 35 2656 5188 1738902
Anhedonia 80.27 52.37 22 2669 799 1743291
Fall 80.18 52.37 62 2629 27152 1716938
Anger 80.10 52.37 29 2662 2637 1741453
Genital atrophy 79.82 52.37 11 2680 0 1744090
Post-traumatic stress disorder 79.66 52.37 18 2673 289 1743801
Orchitis 78.64 52.37 18 2673 307 1743783
Pelvic pain 78.09 52.37 18 2673 317 1743773
Shoulder operation 78.08 52.37 17 2674 228 1743862
Micturition urgency 77.22 52.37 21 2670 740 1743350
Weight decreased 76.23 52.37 56 2635 22697 1721393
Intervertebral disc degeneration 75.98 52.37 20 2671 621 1743469
Arthritis 75.61 52.37 31 2660 3944 1740146
Irritability 75.15 52.37 34 2657 5498 1738592
Blood oestrogen increased 74.24 52.37 12 2679 23 1744067
Breast pain 73.51 52.37 17 2674 304 1743786
Arthroscopy 73.43 52.37 13 2678 52 1744038
Arterial insufficiency 72.06 52.37 12 2679 30 1744060
Oestrogen receptor positive breast cancer 71.61 52.37 10 2681 1 1744089
Malaise 71.46 52.37 60 2631 29505 1714585
Hernia 71.09 52.37 22 2669 1230 1742860
Surgery 70.81 52.37 27 2664 2836 1741254
Temperature intolerance 70.75 52.37 18 2673 487 1743603
Seasonal allergy 69.88 52.37 19 2672 669 1743421
Skin laceration 69.04 52.37 24 2667 1937 1742153
Migraine 68.90 52.37 25 2666 2286 1741804
Urinary tract infection 68.89 52.37 39 2652 10114 1733976
Mood swings 68.55 52.37 24 2667 1978 1742112
Dark circles under eyes 68.19 52.37 12 2679 46 1744044
Dry eye 67.57 52.37 21 2670 1191 1742899
Skin atrophy 67.54 52.37 16 2675 319 1743771
Testicular cyst 67.10 52.37 11 2680 24 1744066
Appendicectomy 66.19 52.37 15 2676 244 1743846
Inguinal hernia 65.71 52.37 20 2671 1057 1743033
Genital pain 65.27 52.37 12 2679 62 1744028
Cholecystectomy 65.26 52.37 17 2674 506 1743584
Mental impairment 65.06 52.37 23 2668 1950 1742140
Partner stress 64.48 52.37 12 2679 67 1744023
Inguinal hernia repair 64.48 52.37 12 2679 67 1744023
Mental disorder 63.86 52.37 25 2666 2818 1741272
Soft tissue mass 63.62 52.37 11 2680 37 1744053
Emotional poverty 63.61 52.37 12 2679 73 1744017
Bipolar disorder 63.41 52.37 18 2673 744 1743346
Psychosexual disorder 63.40 52.37 11 2680 38 1744052
Diverticulum 62.74 52.37 19 2672 987 1743103
Somatic symptom disorder 62.24 52.37 13 2678 141 1743949
Libido disorder 62.15 52.37 12 2679 84 1744006
Ejaculation delayed 62.02 52.37 12 2679 85 1744005
Cerumen impaction 60.85 52.37 12 2679 95 1743995
Chronic fatigue syndrome 60.63 52.37 12 2679 97 1743993
Breast cancer male 60.41 52.37 12 2679 99 1743991
Acrochordon 60.30 52.37 12 2679 100 1743990
Limb operation 60.22 52.37 13 2678 167 1743923
Anxiety disorder 60.13 52.37 14 2677 258 1743832
Rotator cuff syndrome 59.97 52.37 18 2673 907 1743183
Varicose vein 59.93 52.37 14 2677 262 1743828
Mood altered 59.71 52.37 22 2669 2100 1741990
Urinary tract obstruction 59.52 52.37 16 2675 539 1743551
Body fat disorder 59.49 52.37 10 2681 27 1744063
Lymphadenectomy 59.32 52.37 11 2680 60 1744030
Blood testosterone increased 59.19 52.37 14 2677 277 1743813
Depressed mood 58.98 52.37 24 2667 2992 1741098
Hepatic function abnormal 58.54 52.37 31 2660 7043 1737047
Pain in extremity 58.53 52.37 44 2647 18428 1725662
Spinal osteoarthritis 58.43 52.37 17 2674 768 1743322
Sexually transmitted disease 57.26 52.37 9 2682 13 1744077
Bronchitis 57.16 52.37 28 2663 5404 1738686
Scrotal pain 56.11 52.37 12 2679 147 1743943
Prostatic disorder 55.95 52.37 15 2676 500 1743590
Seborrhoeic keratosis 55.89 52.37 12 2679 150 1743940
Herpes simplex 55.77 52.37 16 2675 687 1743403
Affective disorder 55.44 52.37 16 2675 702 1743388
Nasal septal operation 55.42 52.37 9 2682 18 1744072
Muscular weakness 55.40 52.37 34 2657 10215 1733875
Testis cancer 54.64 52.37 13 2678 264 1743826
Rotator cuff repair 54.22 52.37 11 2680 102 1743988
Ventricular extrasystoles 54.21 52.37 20 2671 1916 1742174
Urinary tract disorder 54.05 52.37 14 2677 407 1743683
Alcohol abuse 53.75 52.37 15 2676 582 1743508
Sensory disturbance 53.61 52.37 18 2673 1306 1742784
Terminal dribbling 53.57 52.37 8 2683 6 1744084
Adjustment disorder 53.47 52.37 11 2680 110 1743980
Radical prostatectomy 53.09 52.37 9 2682 26 1744064
Rosacea 52.96 52.37 12 2679 195 1743895
Onychomycosis 52.78 52.37 13 2678 307 1743783
Limb injury 52.75 52.37 18 2673 1372 1742718
Abdominal pain 52.64 52.37 44 2647 21446 1722644
Lethargy 52.52 52.37 29 2662 7155 1736935
Skin lesion 52.52 52.37 22 2669 2950 1741140

Pharmacologic Action:

SourceCodeDescription
ATC D11AX10 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Other dermatologicals
ATC G04CA51 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Alpha-adrenoreceptor antagonists
ATC G04CB01 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Testosterone-5-alpha reductase inhibitors
MeSH PA D058891 5-alpha Reductase Inhibitors
FDA EPC N0000175836 5-alpha Reductase Inhibitor
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D006727 Hormone Antagonists
CHEBI has role CHEBI:59844 antihyperplasia drug
CHEBI has role CHEBI:35497 androgen antagonist
MeSH PA D065088 Steroid Synthesis Inhibitors
MeSH PA D064804 Urological Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Benign prostatic hyperplasia indication 266569009
Male Patterned Baldness indication
Disease of liver contraindication 235856003 DOID:409
Pregnancy, function contraindication 289908002
Breastfeeding (mother) contraindication 413712001
High-Grade Prostate Cancer contraindication
Breast Carcinoma in Males contraindication

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 13.26 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Enzyme INHIBITOR IC50 7.58 WOMBAT-PK DRUG LABEL
3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme INHIBITOR IC50 8.26 WOMBAT-PK DRUG LABEL
Cytochrome P450 2C19 Enzyme IC50 6 DRUG MATRIX
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 Enzyme Ki 4.96 CHEMBL
Cytochrome P450 2C9 Enzyme IC50 5.70 DRUG MATRIX
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Enzyme Ki 8.17 CHEMBL
3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme IC50 9.55 CHEMBL
Steroid 5-alpha-reductase Enzyme Ki 7.26 CHEMBL

External reference:

IDSource
4020167 VUID
N0000148118 NUI
C0060389 UMLSCUI
D00321 KEGG_DRUG
57GNO57U7G UNII
6539 INN_ID
109035006 SNOMEDCT_US
4020167 VANDF
82773 MMSL
003665 NDDF
25025 RXNORM
386963006 SNOMEDCT_US
4728 MMSL
d00563 MMSL
CHEMBL710 ChEMBL_ID
FIT PDB_CHEM_ID
DB01216 DRUGBANK_ID
CHEBI:5062 CHEBI
D018120 MESH_DESCRIPTOR_UI
57363 PUBCHEM_CID
6818 IUPHAR_LIGAND_ID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
PROPECIA HUMAN PRESCRIPTION DRUG LABEL 1 0006-0071 TABLET, FILM COATED 1 mg ORAL NDA 18 sections
PROSCAR HUMAN PRESCRIPTION DRUG LABEL 1 0006-0072 TABLET, FILM COATED 5 mg ORAL NDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0093-7355 TABLET, FILM COATED 5 mg ORAL ANDA 16 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0179-0175 TABLET 5 mg ORAL ANDA 19 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6830 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-089 TABLET, FILM COATED 1 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-090 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 17856-0090 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 31722-525 TABLET, FILM COATED 5 mg ORAL ANDA 11 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 31722-526 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 33261-833 TABLET 5 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 35573-400 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 42291-280 TABLET, FILM COATED 5 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 43598-303 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 43598-390 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-1718 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-3942 TABLET, FILM COATED 1 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-4648 TABLET, COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-4697 TABLET, FILM COATED 5 mg ORAL ANDA 16 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50268-314 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50268-323 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50436-0089 TABLET, FILM COATED 1 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50436-0455 TABLET, COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50436-0927 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections
PROPECIA HUMAN PRESCRIPTION DRUG LABEL 1 54868-4120 TABLET, FILM COATED 1 mg ORAL NDA 19 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 54868-5636 TABLET, FILM COATED 5 mg ORAL ANDA 12 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 55111-171 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 55111-172 TABLET 5 mg ORAL ANDA 18 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 55154-8083 TABLET, FILM COATED 5 mg ORAL ANDA 17 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 57237-061 TABLET, FILM COATED 1 mg ORAL ANDA 17 sections